Last reviewed · How we verify

NCT03039764

Effects of Virtual Reality Based Rehabilitation in Acute Stroke Patients in an Inpatient Rehab Setting

Withdrawn NA Last updated 10 May 2022
What this trial tests

NA trial testing Rapael in Stroke Syndrome. Withdrawn.

Timeline
30 April 2018
Primary endpoint
19 August 2021
19 August 2022

Quick facts

Lead sponsorMontefiore Medical Center
PhaseNA
StatusWithdrawn
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingsingle
Primary purposetreatment
Start date30 April 2018
Primary completion19 August 2021
Estimated completion19 August 2022
Sites1 location across United States

Drugs / interventions tested

Conditions studied

Sponsor

Montefiore Medical Center

Who can join

Adults 18 to 90, any sex, with Stroke Syndrome or Hemiplegia. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

To evaluate the effects of virtual reality-based rehabilitation (Neofect Glove) for newly diagnosed cognitively intact adult dominant hemisphere stroke patients with paresis of their hand in supplementation with conventional occupational therapy to assess whether it improves motor function and speed recovery during inpatient rehabilitation versus conventional occupational therapy alone. Also, what impact does this have on quality of life.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Stroke Syndrome

Currently open trials in the same condition.

Other Montefiore Medical Center trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03039764.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing